Showing results 72 to 91 of 119
< previous
next >
| Issue Date | Title | Author(s) |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
| 2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
| 2020-04 | Molecular mechanisms of action of naringenin in chronic airway diseases | Chin, LH; Hon, CM; Chellappan, DK; Chellian, J; Madheswaran, T; Zeeshan, F; Awasthi, R; Aljabali, AAA; Tambuwala, MM; Dureja, H; Negi, P; Kapoor, DN; Goyal, R; Paudel, KR; Satija, S; Gupta, G; Hsu, A; Wark, P; Mehta, M; Wadhwa, R; Hansbro, PM; Dua, K |
| 2024 | Monoclonal antibodies and antibody-drug conjugates as emerging therapeutics for breast cancer treatment. | Saini, S; Gulati, N; Awasthi, R; Arora, V; Singh, S; Kumar, S; Gupta, G; Dua, K; Pahwa, R; Dureja, H |
| 2020-02-04 | Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease. | Gupta, G; Dahiya, R; Singh, Y; Mishra, A; Verma, A; Gothwal, SK; Aljabali, AAA; Dureja, H; Prasher, P; Negi, P; Kapoor, DN; Goyal, R; Tambuwala, MM; Chellappan, DK; Dua, K |
| - | Multivariate Data Analysis and Central Composite Design-Oriented Optimization of Solid Carriers for Formulation of Curcumin-Loaded Solid SNEDDS: Dissolution and Bioavailability Assessment | Corrie, L; Kaur, J; Awasthi, A; Vishwas, S; Gulati, M; Saini, S; Kumar, B; Pandey, NK; Gupta, G; Dureja, H; Chellapan, DK; Dua, K; Tewari, D; Singh, SK |
| 2020-10 | Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices | Ramanunny, AK; Wadhwa, S; Gulati, M; Singh, SK; Kapoor, B; Dureja, H; Chellappan, DK; Anand, K; Dua, K; Khursheed, R; Awasthi, A; Kumar, R; Kaur, J; Corrie, L; Pandey, NK |
| 2020-04 | Nanocarriers: more than tour de force for thymoquinone. | Rathore, C; Rathbone, MJ; Chellappan, DK; Tambuwala, MM; Pinto, TDJA; Dureja, H; Hemrajani, C; Gupta, G; Dua, K; Negi, P |
| 2020-03-10 | Nanomedicine advances in cancer therapy | Hinge, N; Pandey, MM; Singhvi, G; Gupta, G; Mehta, M; Satija, S; Gulati, M; Dureja, H; Dua, K |
| 2021-01-01 | Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters. | Khanuja, HK; Awasthi, R; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Chellappan, DK; Dua, K; Dureja, H |
| 2023-03-15 | Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases | Dureja, H; Adams, J; Löbenberg, R; Pinto, TDJA; Dua, K |
| 2022-01-01 | Nature bioinspired and engineered nanomaterials | Aljabali, AAA; Obeid, MA; Awadeen, SA; Migdadi, EM; Barhoum, A; Al Zoubi, MS; Chellappan, DK; Mishra, V; Charbe, NB; Dureja, H; Gupta, G; Prasher, P; Dua, K; Tambuwala, MM |
| 2023-08 | Neuroaffedegenerative disease and brain delivery of therapeutics: Bridging the gap using dendrimers | Kaur, A; Singh, N; Kaur, H; Kakoty, V; Sharma, DS; Khursheed, R; Babu, MR; Harish, V; Gupta, G; Gulati, M; Kumar, P; Dureja, H; Alharthi, NS; Khan, FR; Rehman, ZU; Hakami, MA; Patel, M; Patel, R; Zandi, M; Vishwas, S; Dua, K; Singh, SK |
| - | Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation | Awasthi, A; Kumar, B; Gulati, M; Vishwas, S; Corrie, L; Kaur, J; Khursheed, R; Muhammed, RA; Kala, D; Porwal, O; Babu, MR; Chaitanya, MVNL; Kumar, A; Pandey, NK; Dureja, H; Chellappan, DK; Jha, NK; Gupta, G; Prasher, P; Kumar, D; Dua, K; Singh, SK |
| 2020-01-18 | Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance | Gupta, G; Wadhwa, R; Pandey, P; Singh, SK; Gulati, M; Satija, S; Mehta, M; Singh, AK; Dureja, H; Collet, T; Pabreja, K; Chellappan, DK; Dua, K |
| 2024-02-16 | Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation. | Bashir, B; Alam, S; Khandale, N; Birla, D; Vishwas, S; Pandey, NK; Gupta, G; Paudel, KR; Dureja, H; Kumar, P; Singh, TG; Kuppusamy, G; Zacconi, F; Pinto, TDJA; Dhanasekaran, M; Gulati, M; Dua, K; Singh, SK |
| 2020-12-27 | Opening eyes to therapeutic perspectives of bioactive polyphenols and their nanoformulations against diabetic neuropathy and related complications. | Khursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Awasthi, A; Kr, A; Kumar, R; Pottoo, FH; Kumar, V; Dureja, H; Anand, K; Chellappan, DK; Dua, K; Gowthamarajan, K |
| 2022-01-01 | Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design | Dahiya, M; Awasthi, R; Gupta, G; Singh, SK; Gulati, M; Jha, NK; Jha, SK; Sharma, A; Prasher, P; Anand, K; Chellappan, DK; Dua, K; Dureja, H |
| 2021-05 | Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and In Vitro Drug Release Studies. | Gulati, N; Kumar Chellappan, D; Tambuwala, M; A A Aljabali, A; Prasher, P; Kumar Singh, S; Anand, K; Sharma, A; Kumar Jha, N; Gupta, G; Dua, K; Dureja, H |
| 2022-02-11 | Orchestration of Obesolytic Activity of Microbiome: Metabiotics at Centre Stage. | Kapoor, B; Singh, A; Gulati, M; Singh, SK; Rani, P; Alzahrani, Q; Dua, K; Dureja, H; Corrie, L |
